Back to search
Non-Melanoma Skin Cancer (NMSC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Melanoma Skin Cancer (NMSC) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Melanoma Skin Cancer (NMSC) trials you may qualify forThe primary objective of this study is the evaluation of the efficacy of the tissue oxygen imager based on PpIX DF in differentiating benign skin growth from no…
This is a randomized, phase II, double-blind, placebo-controlled trial with planned crossover to the intervention arm after 1 year. Consenting patients with CL…
This clinical trial is looking at two drugs called dabrafenib and trametinib. Dabrafenib and trametinib are approved as standard of care treatment for adult pat…
The Phase 2 study is a multicenter, open-label study of RP1 to further investigate safety and to estimate the efficacy of RP1 at the RP2D in combination with ni…
Non-melanoma skin cancers (NMSC), particularly basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), are the most common malignancies in Cauc…